DOI: https://doi.org/10.36347/sjmcr.2025.v13i11.033

Pages: 2804-2808

Urogenital cancers are fairly common in routine urological practice, and urologists devote a significant portion of their time to their management [1,2]. While epidemiological data are available in Northern countries, in Africa in general, data on their prevalence and mortality are scarce. This was a cross-sectional study conducted in the urology-andrology department of the Fousseyni DAOU hospital in Kayes from January 2018 to October 2024. Two hundred and thirty-two files were collected from observation files, hospitalization register, surgical report register and anatomopathological files. Urological cancers accounted for 3.02% of all outpatient visits and 25.27% of hospitalized patients. One hundred and twenty-four cases (53.45%) of prostate cancer, 105 cases (45.26%) of bladder cancer, and three cases of kidney cancer (1.29%), with an average of 33 cases per year. The average age of patients was 64.68, with a range of 22 to 94 years. The predominant age group was between 61 and 80 years. Males accounted for 162 cases (69.82%) and females for 70 cases (30.17%), with a sex ratio of 2.31. Urological cancers accounted for an average of 14 cases per year. The incidence of prostate cancer among hospitalized patients was 1.30%, with an average of 17.71 cases per year. Adenocarcinoma was the most common histological type, accounting for 78.22% of cases. Bladder cancer came second after prostate cancer, accounting for 45.26% of diagnosed cancers and 1.33% of outpatient visits. Females accounted for 68 cases (64.76%) and males 37 cases (35.23%). Squamous cell carcinoma was the predominant histological type, accounting for 27 cases (25.71%). Kidney cancer was the third most common urological cancer. Three cases underwent surgery. One case (0.43) % of squamous cell carcinoma and 2 cases (0.86%) of clear cell carcinoma.